Research Study

A Multi-Centre, Randomized Study to Assess the Effects of Adaptive Servo Ventilation (ASV) on Survival and Frequency of Hospital Admissions in Patients With Heart Failure (HF) and Sleep Apnea (SA)-The ADVENT-HF Trial
Principal Investigator 
John A. Fleetham

Overview

Body Locations and Systems 
Disorders and Conditions 
Sleep
ClinicalTrials.gov# 
NCT01128816
Status 
Recruiting
Study Start/End 
Apr 11, 2010 to Jan 10, 2018
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Nurit Fox, Research Nurse
Phone 
604-875-4111 ext.67912
Email Address 
nurit.fox@vch.ca
Purpose of Study 

Sleep Apnea (SA) is a disorder that causes pauses in breathing during sleep that expose the heart to oxygen deprivation. It is common in patients with heart failure (HF) where it is associated with increased risk of hospitalizations and death. It is not known however whether treating SA reduces these risks. This study is looking at whether a respiratory device known as Adaptive Servo Ventilation (ASV) can reduce the rate of cardiovascular hospitalizations and death in subjects with HF and SA. Study subjects will randomly receive either their regular medications OR their regular medications plus ASV. They will be followed for approximately 5 years and information relevant to their health will be collected and compared.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.